NEW YORK, Feb. 24, 2011 /PRNewswire/ — Reportlinker.com
announces that a new market research report is available in its
catalogue:
Global Drug-Eluting Stents Industry
http://www.reportlinker.com/p080457/Global-Drug-Eluting-Stents-Industry.html
This report analyzes the worldwide markets for Drug-Eluting
Stents in US$ Million. The report provides separate comprehensive
analytics for the US, Japan, Europe, and Rest of World. Annual
estimates and forecasts are provided for the period 2009 through
2015. Also, a six-year historic analysis is provided for these
markets. The report profiles 39 companies including many key and
niche players such as Abbott Vascular, Angiotech Pharmaceuticals,
Inc., AngioDynamics®, Inc., Boston Scientific, Inc., Boston
Scientific Cardiac Rhythm Management, Biocompatibles International
PLC, Biosensors International Pte Ltd., Cordis Corporation,
Medtronic, Inc., MIV Therapeutics, Inc., and SurModics, Inc.,
Market data and analytics are derived from primary and secondary
research. Company profiles are mostly extracted from URL research
and reported select online sources.
To order this report:
:
Global Drug-Eluting Stents Industry
Check our Company Profile,
SWOT and Revenue Analysis!
Nicolas Bombourg
Reportlinker
Email:
nbo@reportlinker.com
US: (805)652-2626
‘/>”/>
